ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Alkermes Plc (ALKS) Technical (Analysis) Reports Alkermes Plc ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Alkermes Plc (ALKS)

Technical Analysis Report for NASDAQ stock ALKS Alkermes Plc. Dated: 29 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALKS Alkermes Plc then click here. or read Experts views on Alkermes Plc or Forecast & share price targets of Alkermes Plc

Alkermes Plc Opened at 50.50 and Closed at: 48.34, which is -4.47% of previous session's close. It moved within a range of 47.66 and 50.72
The session was a Bearish session with an average volume of 4149600, which is 30.69% of previous session's volumes.

  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 8 days back on short term averages

Support for tomorrow is 46.47 and resistance for tomorrow is 49.53
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 47.09, 45.85 resistance for tomorrow's hourly charts is 50.15, 51.97

10 Day SMA for Alkermes Plc (ALKS) is 52.02 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Alkermes Plc (ALKS) is 52.63 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Alkermes Plc (ALKS) is 47.54 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 40.23 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Alkermes Plc is 35.48 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Alkermes Plc is at 52.63 and 200 DMA is at 35.48, while 50 DMA and 100 DMA are at 47.54 and 40.23 respectively

Alkermes Plc (ALKS) moving average of 20 SMA is at 52.63 and 20 EMA is at 51.43

Alkermes Plc (ALKS) moving average of 50 SMA is at 47.54 and 50 EMA is at 47.84

Alkermes Plc (ALKS) moving average of 100 SMA is at 40.23 and 100 EMA is at 42.93

Alkermes Plc (ALKS) moving average of 200 SMA is at 35.48 and 200 EMA is at 38.24

Alkermes Plc has performed better than Twist Bioscience in short term. Holding Alkermes Plc could be a better choice for now!

Trinity Biotech has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Trinity Biotech, about 3473.59% more returns!

Alkermes Plc has performed better than China Sxt in short term. Holding Alkermes Plc could be a better choice for now!

Si Bone has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Si Bone, about 19.2% more returns!

Natera Inc has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Natera Inc, about 2.3% more returns!

Neogen Corporation has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Neogen Corporation, about 11.96% more returns!

Endra Life has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Endra Life, about 5.71% more returns!

Medicinova Inc has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Medicinova Inc, about 1.64% more returns!

Immuron has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Immuron, about 11.43% more returns!

Helius Medical has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Helius Medical, about 3.61% more returns!

Fortress Biotech has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Fortress Biotech, about 21.63% more returns!

Denali Therapeutics has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Denali Therapeutics, about 3.76% more returns!

Curis Inc has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Curis Inc, about 1334.29% more returns!

Alkermes Plc has performed better than Bioxcel Therapeutics in short term. Holding Alkermes Plc could be a better choice for now!

Atossa Genetics has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Atossa Genetics, about 20.39% more returns!

Alkermes Plc has performed better than Anaptysbio Inc in short term. Holding Alkermes Plc could be a better choice for now!

Amphastar Pharmaceuticals has performed better than Alkermes Plc in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 16.22% more returns!

Alkermes Plc Technical analysis of indicators

Price action analysis of Alkermes Plc (ALKS) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Alkermes Plc stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Alkermes Plc in short term but the sell signal is initial and weak.

Alkermes Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Alkermes Plc in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Alkermes Plc is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 51.36 and Alkermes Plc ALKS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Alkermes Plc ALKS stock. Volume based technical analysis of Alkermes Plc ALKS stock is negative.

Alkermes Plc Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ALKS Alkermes Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALKS Experts View which covers a lot of information including buying and selling signals

ALKS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alkermes Plc or View Candle Stick Charts here

Chart Alkermes Plc (ALKS)  Technical (Analysis) Reports Alkermes Plc [

Videos related to: Alkermes Plc (ALKS) Technical (Analysis) Reports Alkermes Plc ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Alkermes Plc (ALKS)  Technical (Analysis) Reports Alkermes Plc [

 

Back to top